October 2021 - QuartzBio

Title: Advancing Clinical Sample Management with a Virtual Sample Repository

Duration: 30 minutes

You’ll see how a virtual repository delivered via QuartzBio’s translational hub provides visibility into clinical sample status:

Sample visibility across studies, central labs, third party vendors, biorepositories, and disparate source systems
KPI dashboards that report sample status including collection, processing, testing, consent, expiration – while highlighting collection gaps and discrepancies.
Dynamic visualizations to quickly review expected vs actual sample status by patient, time point, and assay type

October 8, 2021 — Sponsors are challenged to keep track of complex sample inventories, both on study and for samples collected as part of completed studies that might be later mined for translational research needs. We frequently hear that teams spend significant time manually cross-referencing spreadsheets of inventory data, to answer questions such as:

“How many whole blood samples with a particular mutation do we have across all phase I studies?”
“Can we report sample expiration status across all of our contracted biorepositories?”
“When we identify a sample of interest, how can we confirm consent status?”

Precision for Medicine is the first biomarker-driven clinical development organization supporting life sciences companies in the use of biomarkers essential to targeting patient treatments. Precision for Medicine is part of Precision Medicine Group, with 3,000 employees in 40 locations.

Web Design and Development by RainCastle Communications.